1. Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer
    Liyu Wang et al, 2022, Frontiers in Oncology CrossRef
  2. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma
    Bingzhi Wang et al, 2021, BMC Gastroenterology CrossRef
  3. Tumor progression-dependent angiogenesis in gastric cancer and its potential application
    Hsi-Lung Hsieh et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
  4. Research progress and prospects of AFP-positive gastric cancer
    Long Zhao et al, 2022, Foregut Surgery CrossRef
  5. Complete remission of alpha-fetoprotein-producing gastric cancer by combined tislelizumab-apatinib treatment of a patient with proficient mismatch repair: a case report
    Jinyu Xiang et al, 2022, World Journal of Surgical Oncology CrossRef
  6. Apatinib Combined with Immune Checkpoint Inhibitor for Advanced Gastric Hepatoid Adenocarcinoma: A Case Report and Review of Literature
    海 周, 2023, Advances in Clinical Medicine CrossRef
  7. Clinicopathological Characteristics of Gastric Cancer with Elevated Serum AFP
    培培 焦, 2024, Journal of Clinical Personalized Medicine CrossRef
  8. p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
    Hyun Joo Bae et al, 2021, Biochemical Pharmacology CrossRef
  9. Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments
    Ruolan Xia et al, 2021, Frontiers in Oncology CrossRef
  10. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study
    Lamei Li et al, 2023, BMC Gastroenterology CrossRef
  11. Hepatoid adenocarcinoma of the stomach effectively treated with capecitabine with oxaliplatin as adjuvant chemotherapy: A case report and literature review
    Jun Amioka et al, 2023, International Journal of Surgery Case Reports CrossRef
  12. Hepatoid adenocarcinoma of the stomach with metastatic choriocarcinoma of the liver: A case report of a rare subtype of gastric cancer with a complex treatment course
    Qiyang Zhou et al, 2022, Frontiers in Surgery CrossRef
  13. Effective Treatment of Cytotoxic Agent Refractory Alpha-Fetoprotein-Producing Gastric Cancer with Ramucirumab: a Case Report and Review of the Literature
    Jun Takada et al, 2019, Journal of Gastrointestinal Cancer CrossRef
  14. New substituted molecular classifications of advanced gastric adenocarcinoma: characteristics and probable treatment strategies
    Bingzhi Wang et al, 2022, Journal of the National Cancer Center CrossRef

  15. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma


    Wei Li et al, 2020, Cancer Management and Research CrossRef
  16. Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
    Massimiliano Salati et al, 2022, Frontiers in Oncology CrossRef
  17. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
    Ya-Kun Wang et al, 2018, World Journal of Gastroenterology CrossRef
  18. Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer
    Daisaku Kamiimabeppu et al, 2023, International Journal of Clinical Oncology CrossRef
  19. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review
    Yansha Sun et al, 2022, Journal of International Medical Research CrossRef
  20. Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
    Ningning Li et al, 2021, Translational Oncology CrossRef